Epidemiology of Retrolental Fibroplasia

Abstract

THE emergence of a new disease is a rare event in the middle of the twentieth century, but for over ten years retrolental fibroplasia has represented a new problem, both clinically and epidemiologically. The challenge to understand causes is not only to be able to prevent the new disease; further knowledge promises to help clarify the vascular basis of ocular and extraocular malformations of the fetus and embryo, and thus to throw light on the etiology and epidemiology of some of the oldest conditions of which there is medical record, the congenital anomalies.Retrolental fibroplasia could not have been widely . . .